(Press-News.org) Researchers from UCL (University College London) have demonstrated how an interplay between nutrition, metabolism and immunity is involved in the process of ageing.
The two new studies, supported by the Biotechnology and Biological Sciences Research Council (BBSRC), could help to enhance our immunity to disease through dietary intervention and help make existing immune system therapies more effective.
As we age our immune systems decline. Older people suffer from increased incidence and severity of both infections and cancer. In addition, vaccination becomes less efficient with age.
In previous BBSRC funded work, Professor Arne Akbar's group at UCL showed that ageing in immune system cells known as 'T lymphocytes' was controlled by a molecule called 'p38 MAPK' that acts as a brake to prevent certain cellular functions.
They found that this braking action could be reversed by using a p38 MAPK inhibitor, suggesting the possibility of rejuvenating old T cells using drug treatment.
In a new study published today in Nature Immunology the group shows that p38 MAPK is activated by low nutrient levels, coupled with signals associated with age, or senescence, within the cell.
It has been suspected for a long time that nutrition, metabolism and immunity are linked and this paper provides a prototype mechanism of how nutrient and senescence signals converge to regulate the function of T lymphocytes.
The study also suggests that the function of old T lymphocytes could be reconstituted by blocking one of several molecules involved in the process. The research was conducted at UCL alongside colleagues from Complejo Hospitalario de Navarra, Pamplona, Spain.
The second paper, published in The Journal of Clinical Investigation, showed that blocking p38 MAPK boosted the fitness of cells that had shown signs of ageing; improving the function of mitochondria (the cellular batteries) and enhancing their ability to divide.
Extra energy for the cell to divide was generated by the recycling of intracellular molecules, a process known as autophagy. This highlights the existence of a common signaling pathway in old/senescent T lymphocytes that controls their immune function as well as metabolism, further underscoring the intimate association between ageing and metabolism of T lymphocytes.
This study was conducted by researchers from UCL, Cancer Research UK, University of Oxford and University of Tor Vergata, Rome, Italy.
Professor Arne Akbar said: "Our life expectancy at birth is now twice as long as it was 150 years ago and our lifespans are on the increase. Healthcare costs associated with ageing are immense and there will be an increasing number of older people in our population who will have a lower quality of life due in part to immune decline. It is therefore essential to understand reasons why immunity decreases and whether it is possible to counteract some of these changes.
"An important question is whether this knowledge can be used to enhance immunity during ageing. Many drug companies have already developed p38 inhibitors in attempts to treat inflammatory diseases. One new possibility for their use is that these compounds could be used to enhance immunity in older subjects. Another possibility is that dietary instead of drug intervention could be used to enhance immunity since metabolism and senescence are two sides of the same coin."
INFORMATION:
Notes to editors
Contact: Chris Melvin, BBSRC media officer, 01793 414694, chris.melvin@bbsrc.ac.uk
References:
The kinase p38 activated by the metabolic regulator AMPK and scaffold TAB1 drives the senescence of human T cells by Lanna et al is published in Nature Immunology.
The study was funded by BBSRC and the Medical Research Council.
p38 signaling inhibits mTORC1-independent autophagy in senescent human CD8+ T cells by Henson et al is published in The Journal of Clinical Investigation.
The study was funded by BBSRC, the Medical Research Council, National Institute for Health Research, Wellcome Trust, Lady Tata Memorial
Trust and Cancer Research UK.
Video: A UCL video about the research can be viewed at: http://youtu.be/oQ-unC7D9i4. Please note this video will be unlisted until the embargo lifts and should not be shared publically until that time.
About BBSRC
The Biotechnology and Biological Sciences Research Council (BBSRC) invests in world-class bioscience research and training on behalf of the UK public. Our aim is to further scientific knowledge, to promote economic growth, wealth and job creation and to improve quality of life in the UK and beyond.
Funded by Government, BBSRC invested over £484M in world-class bioscience in 2013-14. We support research and training in universities and strategically funded institutes. BBSRC research and the people we fund are helping society to meet major challenges, including food security, green energy and healthier, longer lives. Our investments underpin important UK economic sectors, such as farming, food, industrial biotechnology and pharmaceuticals.
For more information about BBSRC, our science and our impact see: http://www.bbsrc.ac.uk
For more information about BBSRC strategically funded institutes see: http://www.bbsrc.ac.uk/institutes
About UCL (University College London)
Founded in 1826, UCL was the first English university established after Oxford and Cambridge, the first to admit students regardless of race, class, religion or gender, and the first to provide systematic teaching of law, architecture and medicine. We are among the world's top universities, as reflected by performance in a range of international rankings and tables. UCL currently has almost 29,000 students from 150 countries and in the region of 10,000 employees. Our annual income is more than £900 million.
http://www.ucl.ac.uk | Follow us on Twitter @uclnews | Watch our YouTube channel YouTube.com/UCLTV
Are you as old as what you eat? Researchers learn how to rejuvenate aging immune cells
2014-08-24
ELSE PRESS RELEASES FROM THIS DATE:
Stanford bioengineers close to brewing opioid painkillers without using opium from poppies
2014-08-24
For centuries poppy plants have been grown to provide opium, the compound from which morphine and other important medicines such as oxycodone are derived.
Now bioengineers at Stanford have hacked the DNA of yeast, reprograming these simple cells to make opioid-based medicines via a sophisticated extension of the basic brewing process that makes beer.
Led by Associate Professor of Bioengineering Christina Smolke, the Stanford team has already spent a decade genetically engineering yeast cells to reproduce the biochemistry of poppies with the ultimate goal of producing ...
'Haven't my neurons seen this before?'
2014-08-24
PITTSBURGH—The world grows increasingly more chaotic year after year, and our brains are constantly bombarded with images. A new study from Center for the Neural Basis of Cognition (CNBC), a joint project between Carnegie Mellon University and the University of Pittsburgh, reveals how neurons in the part of the brain responsible for recognizing objects respond to being shown a barrage of images. The study is published online by Nature Neuroscience.
The CNBC researchers showed animal subjects a rapid succession of images, some that were new, and some that the subjects ...
Neuroscience and big data: How to find simplicity in the brain
2014-08-24
PITTSBURGH—Scientists can now monitor and record the activity of hundreds of neurons concurrently in the brain, and ongoing technology developments promise to increase this number manyfold. However, simply recording the neural activity does not automatically lead to a clearer understanding of how the brain works.
In a new review paper published in Nature Neuroscience, Carnegie Mellon University's Byron M. Yu and Columbia University's John P. Cunningham describe the scientific motivations for studying the activity of many neurons together, along with a class of machine ...
'Just right' plant growth may make river deltas resilient
2014-08-24
BLOOMINGTON, Ind. -- Research by Indiana University geologists suggests that an intermediate amount of vegetation -- not too little and not too much -- is most effective at stabilizing freshwater river deltas.
The study, "Optimum vegetation height and density for inorganic sedimentation in deltaic marshes," was published online Aug. 24 by Nature Geoscience. The findings may help guide restoration of river deltas, such as those near the mouth of the Mississippi River, which are under threat as sea levels rise.
Authors are William Nardin, a postdoctoral fellow in the ...
Deletion predicts survival in advanced non-small cell lung cancer
2014-08-22
DENVER – Bcl-2-like protein 11 (BIM) deletion in advanced non-small cell lung cancer (NSCLC) is associated with shorter progression free survival (PFS) in epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) or chemotherapy treated Asian patients. Also, BIM deletion independently predicts overall survival (OS) of advanced NSCLC patients.
The BIM protein can activate the programmed cell death also known as the apoptotic pathway in cells. BIM deletion has been detected in 12.8% of the Asian population but is very rarely observed in the Caucasian population. ...
Novel oncogenic RET mutation found in small cell lung cancer
2014-08-22
DENVER – For the first time an oncogenic somatic mutation at amino acid 918 in the RET (rearranged during transfection) protein has been identified in small cell lung cancer (SCLC) tumors and enforced expression of this mutation within SCLC cell lines produced increased intracellular signaling and cell growth.
SCLC is a highly malignant form of lung cancer representing 15% of all lung cancers and is strongly associated with tobacco smoking. NSCLC, representing 85% of lung cancer, has been extensively examined for genomic alterations and targeted therapies are approved ...
High concordance between EGFR mutations from circulating-free tumor DNA and tumor tissue in non-small cell lung cancer
2014-08-22
DENVER – Epidermal growth factor receptor (EGFR) mutations found in the circulating free tumor DNA (ctDNA) from the plasma of advanced non-small cell lung cancer (NSCLC) patients correlates well with the EGFR mutations from patient-matched tumor tissue DNA.
EGFR tyrosine kinase inhibitor (TKI) therapy is approved for EGFR activating mutation positive patients with advanced NSCLC, but the standard for determining mutation status is with DNA derived directly from tumor tissue, which can be limited or not available. A more abundant and less invasive source of tumor DNA may ...
Study shows cognitive-behavioral coping skills training has positive effects on rheumatoid arthritis
2014-08-22
DETROIT – Rheumatoid arthritis (RA), a complex autoimmune disease that affects 1 to 2 percent of adults, requires patients to not only cope with pain, disability and joint disfigurements, but also other stressors such as disrupted work, family life and marital functioning. While many pharmacological advances help some RA patients, residual pain and disability is common. In addition, some patients avoid newer medications due to their high cost or side effects. Because of this, there is interest in psychosocial interventions for RA such as cognitive-behavioral and emotional ...
Study shows Hera Therapeutics compound combats HPV types that cause most cervical cancer
2014-08-22
La Jolla, CA – Research presented at the 29th Annual International Papillomavirus Conference shows that a therapy being developed by Hera Therapeutics Inc. combats three types of human papillomavirus, including the two that cause 70 percent of all cervical cancer.
When tested in several cultured human cell models, HTI-1968 blocked the replication of HPV-16, HPV-18 and HPV-11 cells, according to Louise T. Chow, Ph.D. and Thomas Broker, Ph.D., who presented the findings at the Seattle conference. The National Institute of Allergy and Infectious Diseases in the National ...
Penn study: Electronic alerts significantly reduce catheter-associated urinary tract infections
2014-08-22
(PHILADELPHIA) - A Penn Medicine team has found that targeted automated alerts in electronic health records significantly reduce urinary tract infections in hospital patients with urinary catheters. In addition, when the design of the alert was simplified, the rate of improvement dramatically increased.
The alerts help physicians decide whether their patients need urinary catheters in the first place and then alert them to reassess the need for catheters that have not been removed within a recommended time period. The electronic alert, developed by medical researchers ...